As an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus, as monotherapy and in dual combination with metformin, a sulphonylurea (SU), a thiazolidinedione (TZD) or insulin when diet, exercise and a single treatment couldn't improve sugar levels